Info

Psychedelics Today

Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
RSS Feed Subscribe in Apple Podcasts
Psychedelics Today
2024
April
March
February
January


2023
December
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May


Categories

All Episodes
Archives
Categories
Now displaying: November, 2023
Nov 28, 2023

In this episode, Kyle interviews Bessel van der Kolk, MD: pioneer clinician, researcher, and educator on traumatic stress; Founder of the Trauma Research Foundation; Professor of Psychiatry at Boston University Medical School; Principal Investigator of the Boston site of MAPS’ MDMA-assisted psychotherapy study; and author of the #1 New York Times Science best seller, The Body Keeps the Score: Brain, Mind, and Body in the Treatment of Trauma.

As of this recording, van der Kolk was publishing his last paper and closing down his laboratory, so he looks back on his past: being part of the group who put together the first PTSD diagnosis in the 80s; the early days of psychedelic research and how he discouraged Rick Doblin and Michael Mithoefer from pursuing MDMA research; how the DSM has no scientific validity and was never meant for the diagnosing it’s being used for; how science wasn’t seeing the whole picture and pushing us mindlessly from medication to medication; and how trauma research has evolved over the years as society learned more about how the mind actually works. 

He discusses the struggle to validate “softer” sciences; the impracticality and price of the MAPS protocol and the need for more group and sitter/experiencer frameworks; the efficacy of psychodrama and how that plays out in group sessions; his interest in using the Rorschach test more; how rolfing helped him; the problem with diagnosis and people becoming their illnesses; bodywork, somatic literacy, and how disconnected most people are from their bodies; and how, in all the healing frameworks he’s explored, he has never seen anything work as profoundly as psychedelic-assisted therapy.

Click here to head to the show notes page

Nov 24, 2023

In this episode, Joe interviews Dana Lerman, MD: a decade-long infectious disease consultant who has since been trained in psychedelic-assisted therapy, ecotherapy, and Internal Family Systems, and is the Co-Founder of Skylight Psychedelics, where she prescribes IM ketamine and trains therapists who work with it.

Lerman tells her story: how working with kids with cancer made her want to learn medicine, what it was like working as an infectious disease expert during COVID, and how fascinating it has been to start with modern medicine and then fully embrace the traditional frameworks of ayahuasca ceremonies. She has realized that part of her role is to bring that intention, ceremony, and inner healing intelligence to modern medicine – that that will greatly benefit patients as well as clinicians who naturally want to be healers but are burnt out by the bureaucracy and distractions of the faulty container they find themselves in. Skylight Psychedelics is working on opening a clinical research division, researching psychedelics for Long COVID, and bringing in-person psychedelic peer support services to emergency rooms.

She also discusses intergenerational trauma and how psychedelics have affected her parenting; the impossibility of informed consent in psychedelics and why there should be disclaimers as well as instructions; accessibility, the need for insurance to cover psychedelic-assisted therapy, and why the price of these expensive treatments actually makes sense; why we should be sharing stories of mistakes and things going wrong during ceremonies; and why one of the biggest things we can do to further the cause is to educate our children and parents about psychedelics.

Click here to head to the show notes page

Nov 21, 2023

In this episode, Joe interviews neuroscientist, board-certified psychiatrist, health tech entrepreneur, inventor, and Co-Founder & Chief Medical Officer at Apollo Neuro: Dr. David Rabin, MD, Ph.D.

He talks about his path to psychiatry; his realization that trauma and chronic stress were primary themes at the root of most mental illness; and the creation, research and implementation of the Apollo wearable: the first scientifically-validated wearable technology designed to improve energy, focus, and relaxation based on touch therapy. The idea was born from Rabin asking himself: If we're all starved for touch and constantly feeling unsafe, our bodies prefer a calm, soothed state, and MDMA seems to work by amplifying feelings of safety and essentially telling our brains, "you're safe enough to heal now," could a rhythmic vibration programmed to stimulate touch receptors and put our bodies into a meditative state fool our brains into the same perceived feeling of safety – especially if that stimulation is constant? Would our nervous systems be able to tell the difference? So far, the data seems to prove that this technology works. 

He discusses what they learned from initial research about how people were using their Apollo wearables; heart rate variability and what changes it; MAPS' Phase III MDMA-assisted psychotherapy results; the idea of the inner healer; using the Apollo in conjunction with ketamine and other psychedelics to ease pre-experience anxiety; and the concept of MDMA-assisted psychotherapy as reverse trauma, the reality that it could stop epigenetic memory, and the question of whether or not the Apollo can do this on its own.

Apollo Neuro is continuing their research by running 14 different trials right now, and if you ever participated in a MAPS trial, you're eligible for a free wearable. If you're just curious about trying the Apollo, you can receive $50 off using this link

Click here to head to the show notes page.

Nov 17, 2023

In this episode of Vital Psychedelic Conversations, David speaks with two current Vital students: Certified Depth Hypnosis Practitioner and Founder and Executive Director of Zoo Labs, Vinitha Watson, CHT; and artist and outdoorsman with decades of experience in bodywork, structural integration, and Vipassana meditation: Judson Frost.

They talk about their personal paths: Watson’s work educating musicians about the music business and their value with Zoo Labs and Frost’s work as an artist; as well as how their experience as parents has grounded them, and how they found Vital. They discuss the importance of integration, having a process, and recognizing how long that can take; being adequately prepared and learning mindfulness skills ahead of a journey; and bringing courage to the space (and as the space-holder, encouragement). They talk about how they hold space, and how one needs to view integration from a spiritually-open perspective to enable people to find their own meanings behind what they experienced. 

They discuss how Watson uses a combination of hypnotherapy, transpersonal psychology, and buddhism to create a slowed down mystical experience; how hypnotherapy can benefit a psychedelic experience; bodywork and how we can’t view the mind and body separately; and more. And since they’re nearing the end of their Vital experience, they discuss what they’ve gotten out of it, and reflect on something they didn’t expect: a collective feeling of regenerative healing inside their Vital community.

Click here to head to the show notes page.

Nov 14, 2023

In this episode, Joe interviews internationally renowned musician, comedian, writer, and actor, Reggie Watts. Watts starred on “Comedy Bang! Bang!,” most recently was the bandleader on CBS’s “The Late Late Show with James Corden” for the last 8 seasons, and just released his memoir, "Great Falls, MT."

Watts discusses his early days of LSD use and how he felt psychedelics and cannabis were useful (in contrast to alcohol); how movies and TV rarely get the psychedelic experience right (and is that because writers haven’t experienced it?); and how the Situationist Movement inspired his concept of being a “disinformationist,” which he uses to bring an instability and psychedelic nature to his shows. And he discusses ketamine: why he loves it (especially with other people), a party he recently attended where everyone was open to trying it together, and why the group collectively agreeing to go deeper is so important to the experience. 

He shares his thoughts on treating certain drugs as bases and others as modifiers, and how the wrong drugs are being treated as bases; the negative feedback loops some drugs (cocaine, nitrous oxide) send us into; psychedelic exceptionalism and the low quality, synthesized drugs created solely out of capitalistic greed; microdosing and the question of whether or not it’s become popular out of a fear of going deeper; what he wants to bring to to the psychedelic conversation; and why sometimes (in the right context), “going off the rails” can be a great thing.

Click here to head to the show notes page.

Nov 10, 2023

In this episode, Kyle interviews Ted Riskin, LCSW: psychotherapist running group KAP sessions and certified in Core Energetics, Internal Family Systems, and Holotropic Breathwork, which he has taught in various forms for 26 years.

He discusses group ketamine-assisted psychotherapy: how he runs sessions, why being welcomed and loved in a group seems to be a bigger factor than the psychedelic, how he came to combine IFS with ketamine or breathwork, and why exploring the parts work of IFS seems to work so well with non-ordinary states of consciousness. And he talks about two complications we often don’t think about with Group KAP: the challenge of getting our different parts to all truly consent to an experience (and how do you get them to?), and how very safe spaces can inspire oversharing, and sadly, subsequent shame.

He discusses knowing when to use a non-directive approach vs. intervening; how people often learn more about themselves as a sitter; using core energetics before experiences to move energy we’re often afraid to work with; the importance of embracing anger (when necessary); memory reconsolidation and bringing exiles from the past into the present; the concept of double bookkeeping; and finding the magic in realizing that sometimes, just being there (“being a useless person” as he says) is all that’s needed.

Click here to head to the show notes page

Nov 7, 2023

In this episode, Joe interviews Imran Khan: Executive Director of the UC Berkeley Center for the Science of Psychedelics.

Khan shares his journey into the world of science and policymaking, beginning with science journalism and inspired by David Nutt’s famous ‘Equicy’ paper and subsequent firing for telling the truth. Realizing how strong the disconnect was between political and science worlds, his goal became to represent science when it comes under attack; using campaigning, lobbying, advocacy work, etc., and essentially becoming a translator between science and society – bringing these overly complicated concepts down to a level every day culture can understand. At UC Berkeley, he’s focusing on research, training scientists to be better communicators, educating the public on the benefits of psychedelics, and trying to make research more trustworthy.

He discusses the word “science” and how it’s used to describe lots of things; the hard problem of consciousness; color constancy, perception, and the influence of priors; the risk of abuse in all therapies; trust and why people don’t always “trust the science”; the risks of putting too much faith in experience insights; the word “sacred”; and more. He concludes by discussing the findings of the first UC Berkeley psychedelic survey, which revealed public sentiments and attitudes towards psychedelics, and, while mostly positive, truly proved the need for people like Khan to be out there educating the public.

Click here to head to the show notes page

Nov 3, 2023

In this episode of Vital Psychedelic Conversations, David interviews Erika Dyck: Vital instructor, historian, professor, author, and editor of the new book, Expanding Mindscapes: A Global History of Psychedelics; and Jono Remington-Hobbs: graduate of the first cohort of Vital, coach, facilitator, and now, Co-Founder of Kaizn, an experiential wellness company with a strong focus on community, creating a feeling of safety, and modern rites of passage. 

They talk a lot about rites of passage and how they create liminal spaces to reflect on the deeper questions we need to ponder but our culture doesn’t allow time for. They talk about how categorization took us away from tradition; how so much of what we get out of these experiences isn’t related to psychedelics at all; why we struggle with connection in the digital age; the power of community as medicine and recognizing a kinship in others; and why we need to integrate our heads and hearts and live more heart-led lives.

They also dive into why cultures have always sought out non-ordinary states of consciousness; how our current state of needing to make sense of a chaotic world is similar to the mindstate of the 60s; psychedelics’ success in palliative care; coaching and why it should be attached to therapy; the creation of the word “psychedelic”; flow states and discovering the intrinsic calling we all have; and the Vital question that starts the podcast out: Are psychedelics the future, or will psychedelics just bring about a different way to think about the future?

Reminder that we’re accepting applications for Vital 2024 now until December 21!

Click here to head to the show notes page

1